Stock Ratings / Consumer Discretionary / BYAH / options

BNKK (45) CABR (38) YCBD (43) UG (70) ⌘ Pro Terminal →

Park Ha Biological Technology Co. Ltd. (Class A) (BYAH) Options Positioning, Max Pain & Unusual Sweeps

$2.30 +1.71% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

Park Ha Biological Technology Co. Ltd. (Class A) (BYAH) carries a Roarable Rating of D+ (Sell) with 57/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D+ • SELL / AVOID Cap $7.9M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk C-

Each axis scored 0–20

12M PRICE TARGET CONE-0.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BYAH)Realized 20D OHLCV Swing Band: ±12.5%

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±12.5%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (BYAH)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for BYAH.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BYAH)

✓Walkthrough of BYAH's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

BYAH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -73.74%▲ RESISTANCE BREAKOUT

2026-10-30O $2.21H $2.31L $2.15C $2.30VOL 15.4K

RES: $0.88SUP: $1.60SMA50: $2.49SMA200: $10.86

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BYAH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BYAH Butterfly Map → + Track BYAH →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BYAH today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BYAH. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for BYAH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BYAH)

Consumer Discretionary Rank #491 of 1011 ⚔️ BNKK vs BYAH Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (BYAH vs. BNKK, CABR, YCBD, UG)

Industry: Package Goods/Cosmetics (23 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Park Ha Biological Technology Co. Ltd. (Class A) (BYAH) ranks #491 by composite RQD confidence (57/100, grade D+) and #945 by equity capitalization ($7.9M). Within this direct 5-issuer industry benchmark cohort, UG leads on earnings valuation at 14.5x trailing P/E, while UG leads on capital efficiency and profitability with 17.8% ROIC and — gross margin. UG currently holds the highest overall quantitative score in the immediate peer group at 70/100 (B-) compared with BYAH at 57/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
BYAH ACTIVE Park Ha Biological Technology Co. Ltd. (Class A)	D+	57/100	—	94.4%	—	+1.71%	$7.9M	Benchmark Subject
BNKK Bonk Inc.	D	45/100	—	58.5%	-35.0%	-2.48%	$9.4M	/bnkk-vs-byah →
CABR Caring Brands Inc.	D-	38/100	—	55.6%	-35.0%	-4.46%	$11.2M	/cabr-vs-byah →
YCBD cbdMD Inc.	D-	43/100	—	62.4%	-30.4%	+4.56%	$4.3M	/ycbd-vs-byah →
UG United-Guardian Inc.	B-	70/100	14.5x	—	17.8%	-1.19%	$30.6M	/ug-vs-byah →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-10-31 • CIK 0001986247

In its most recent audited fiscal period (FY2025, filed 2025-10-31), Park Ha Biological Technology Co. Ltd. (Class A) (BYAH) reported GAAP revenue of $2.5M (+6.0% vs. FY2024 revenue of $2.4M , and +2.7% cumulative change since FY2023) , GAAP net income of -$24.4M, operating cash flow of $85.9K, and free cash flow of $85.9K (-91.1% YoY). On the balance sheet, BYAH closed FY2025 with $6.0M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-10-31	$2.5M	-$24.4M	$85.9K	$85.9K	$6.0M	—
FY2024 (FY)	2024-10-31	$2.4M	$478.6K	$960.5K	$960.5K	—	—
FY2023 (FY)	2023-10-31	$2.5M	$852.0K	$126.5K	$126.5K	—	—

3. BYAH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BYAH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Park Ha Biological Technology Co. Ltd. (Class A) (NASDAQ: BYAH) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 57/100 at a spot price of $2.30 (+1.71% 1D, market cap $7.9M). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 7/20. Across 1011 tracked Consumer Discretionary issuers, BYAH ranks #491 in composite RQD confidence.

How does BYAH compare to BNKK and CABR in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Package Goods/Cosmetics), BYAH carries a Roarable D+ (57/100 RQD), trailing P/E of N/A, gross margin of 94.4%, and ROIC of —. By comparison, BNKK (Bonk Inc.) holds a D grade (45/100 RQD, P/E N/A, ROIC -35.0%, cap $9.4M) and CABR (Caring Brands Inc.) posts a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $11.2M). Among the 5-stock peer group, UG leads on earnings multiple (14.5x) while UG leads on capital efficiency (17.8% ROIC).

What are the biggest fundamental strengths and SEC risk factors for BYAH?

Per BYAH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-10-31, CIK 0001986247), Park Ha Biological Technology Co. Ltd. (Class A) generated $2.5M in revenue (+6.0% YoY), -$24.4M in net income, and $85.9K in free cash flow against $6.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is BYAH trading relative to its 50-day, 200-day, and 52-week technical levels?

BYAH last traded at $2.30 (+1.71% on volume of 2,204 shares), positioning the stock -7.63% below its 50-day simple moving average ($2.49) and -78.82% below its 200-day simple moving average ($10.86). Across its 52-week range of $1.90 to $158.00, BYAH sits at the 0.3% percentile with a 14-day RSI of 42.3 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($2.01 to $2.59).